| abstract |
Disclosed herein are reversible and irreversible inhibitors of Bruton-type tyrosine kinase (Btk). Also disclosed are pharmaceutical compositions comprising the present compounds. Methods for using Btk inhibitors alone or in combination with other therapeutic agents for the treatment of autoimmune diseases or conditions, heterologous immune diseases or conditions, cancers including lymphomas, and inflammatory diseases or conditions be written. 【Selection chart】 None |